GO
Loading...

Gilead Sciences Inc

More

  • NEW YORK, Dec 26- U.S. stocks rose on Friday, with major indexes hitting records and on track for a second straight weekly advance, though trading was light with many traders still out for the Christmas holiday. The advance continued Wall Street's recent upward bias, with the S&P up about 6 percent from a recent closing low hit earlier this month.

  • NEW YORK, Dec 26- U.S. stocks rose on Friday, with major indexes hitting new records and on track for a second straight weekly advance, though trading was light with many traders still out for the Christmas holiday. The advance continued Wall Street's recent upward bias, with the S&P up about 6 percent from a recent closing low hit earlier this month.

  • *Markets on track for positive week, indexes near records. NEW YORK, Dec 26- U.S. stock index futures pointed to a higher open on Friday, putting major indexes on track for a second straight weekly advance, though moves were likely to be slight with few market catalysts and many traders still out for the Christmas holiday. Wall Street has rallied of late, with both the...

  • *Initial jobless claims fall for fourth straight week. *Biotech shares rebound after sharp two-day decline; energy falls. NEW YORK, Dec 24- U.S. stocks closed flat in a short session on Wednesday as investors found few reasons to push major indexes to their sixth straight day of gains despite strength in biotechs and bullish labor market data.

  • *Initial jobless claims fall for fourth straight week. *Equity markets close at 1 p.m. in holiday-shortened session. NEW YORK, Dec 24- U.S. stocks edged higher on Wednesday, with the Dow and S&P 500 at records and on track for a sixth straight daily advance as biotech stocks rallied and data pointed to improving economic conditions.

  • Cramer Remix: These stocks are winners Tuesday, 23 Dec 2014 | 7:11 PM ET
    Jim Cramer on Mad Money.

    From retail to restaurants, "Mad Money" host Jim Cramer is naming his top buys in the wake of the Dow hitting 18K.

  • Cramer: Hunt for bad biotechs in your portfolio Tuesday, 23 Dec 2014 | 6:16 PM ET

    The biotech sector has made a drastic change in the past few days. Jim Cramer goes off the charts to find out if they could be headed down further.

  • After-hours buzz: Cal-Maine Foods, Gilead & Sony Tuesday, 23 Dec 2014 | 5:00 PM ET

    Check out which companies are making headlines after the bell Tuesday: Cal-Maine Foods, Gilead & Sony.

  • Record-setting day: Dow's first finish above 18,000 Tuesday, 23 Dec 2014 | 4:06 PM ET
    A trader works on the floor of the New York Stock Exchange.

    Stocks furthered record gains Tuesday after the economy expanding in the third quarter by the most in 11 years.

  • LOS ANGELES, Dec 23- Express Scripts, the largest manager of prescription drug plans for U.S. employers, is taking an increasingly aggressive stance in price negotiations with pharmaceutical companies after winning discounts on medications with a strategy introduced last year. On Monday, Express Scripts said it lined up a cheaper price for AbbVie Inc's newly...

  • NEW YORK, Dec 23- U.S. stocks advanced on Tuesday, as the Dow climbed above the 18,000 mark for the first time in history and the S&P 500 set a new intraday record after an unexpectedly strong report on economic growth. The gains pushed the Dow as high as 18,051.14, and the index is now up about 175 percent from a 12- year low hit on March 9, 2009. "What was most interesting...

  • NEW YORK, Dec 23- U.S. stock index futures were little changed on Tuesday, after the Dow and S&P 500 closed at fresh records and ahead of a raft of economic data. *Major Wall Street indexes have risen for four straight sessions, pushing the benchmark S&P index to its 50th record high of the year. The S&P has risen 5.4 percent over that period, its best 4- day run since July...

  • LOS ANGELES, Dec 23- Express Scripts, the largest manager of prescription drug plans for U.S. employers, is taking an increasingly aggressive stance in price negotiations with pharmaceutical companies after winning discounts on medications with a strategy introduced last year. On Monday, Express Scripts said it lined up a cheaper price for AbbVie Inc's newly...

  • Cramer Remix: This sector is on fire Monday, 22 Dec 2014 | 7:05 PM ET
    Jim Cramer on Mad Money.

    It’s alive! "Mad Money" host Jim Cramer has the way to play an industry that’s buzzing again.

  • Your first trade for Tuesday Monday, 22 Dec 2014 | 6:28 PM ET

    The "Fast Money" traders give their final trades of the day.

  • Cramer: Competition + stocks = Cold-blooded killer Monday, 22 Dec 2014 | 6:11 PM ET
    Facebook headquarters

    Price competition might be a good thing for the consumer, but Jim Cramer recommends running far from the stocks—especially in this sector.

  • NEW YORK, Dec 22- Equity markets worldwide edged higher on Monday after rising expectations for more European stimulus supported shares in the region, while year-end buying underpinned U.S. stocks. Anticipation of outright government bond buying from the European Central Bank and greater political stability in Greece boosted European bourses.

  • Dec 22- The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences Inc's treatments after trying for nearly a year to win a deeper discount. Express Scripts' move reignited investor concerns that pharmaceutical companies...

  • *Company to test combination hep C drug in 2015. Dec 22- Data from Achillion Pharmaceuticals Inc's hepatitis C drug trials showed the company could develop a shorter-duration treatment rivaling offerings from Gilead Sciences Inc and Abbvie Inc.. The biotechnology company's shares rose as much as 17 percent to $16.77, their highest in more than seven years.

  • NEW YORK, Dec 22- Equity markets worldwide edged higher on Monday after European energy shares rose, even as oil prices remained volatile. A rebound in European energy shares and greater political stability in Greece boosted European bourses. Stocks in Moscow also gained, with the dollar-traded up almost 7 percent following news that oil firm Rosneft had paid...